echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > 18 large varieties, five provinces/cities began to take the volume of procurement (with list)

    18 large varieties, five provinces/cities began to take the volume of procurement (with list)

    • Last Update: 2020-10-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medicine Network October 15th, soon after, a new price war is about to begin.
    18 varieties, five provinces /cities with volume collection October 14, Yunnan Province drug centralized procurement platform hung out "Chongqing Province, Yunnan Province, Guangxi Zhuang Autonomous Region, the first batch of commonly used drugs joint band procurement documents (draft for comments)," meaning that the first batch of commonly used drugs in five provinces (cities, districts) combined with volume procurement, officially began;
    In the officially published Draft for Comments, 18 products include phenyl sulfonate lamine chloropropine, pyridoxine, cephalosporine, vitolazole sodium, zucarnitine, hydrochloric acid kawasium, growth inhibitor, sodium nitrosin chloride, sodium reberazine, meloxilin, cephalosporineand tetracycline.
    , the vast majority of the varieties involved in the five provincial alliances are injection forms.
    Based on the agreed purchase volume of this provincial volume purchase, 70% of the purchase demand reported by medical institutions in Chongqing, Guizhou, Yunnan, Hunan and Guangxi Zhuang Autonomous Region from January 1, 2019 to December 31, 2019 is determined.
    and pyridoxirin sodium talapartan (8:1), pylasillin sodium talapartan (4:1), cephalosporine, hydrochloric acid, sodium nitrochloride, meloxilin, Cephalosporine , sodium valproate, and cyclocycline are based on 60% of the agreed procurement requirements reported by medical institutions from January 1, 2019 to December 31, 2019.
    documents show that the principle of allocation of procurement volume is as follows: the actual selection of enterprises for 1, product procurement volume is not less than the quality level agreed procurement volume calculation, the base of 100%;
    , as in the case of generic drugs, one of the quality levels is not selected, the quality level agreed to purchase 50% of the amount divided into another quality level.
    to distinguish the quality level, the national lowest price according to the Draft for Comments, the joint collection of varieties are divided into two quality levels, the quotation requirements shall not be higher than the current implementation of the national minimum price.
    First quality level: patented drugs, original research drugs, matching preparations, chemicals newly registered classification approved drugs and drugs included in the "China Listed Drugs Listed Listed" drugs, access to the European Union CGMP, the United States FDA, Japan JGMP certification and export of mainstream markets in Europe, the United States, Japan domestic drugs.
    the second quality level: other imported drugs and domestic generics in addition to the first quality level.
    from the current publication of the procurement of varieties of provincial belt procurement list, injections because of the high amount of procurement, large amount of use and so on, is the focus of collection around the object.
    injections are the main clinical dosage forms.
    data show that injections account for more than 60% of China's public hospital drug market, of which chemical injections even reached 70%.
    Huahua University of Science and Technology School of Medical and Health Management Chen Wei, Rao Yuanhong has written that the chemical injection market is huge, but China's chemical injection generics widely exist a weak research base, in the starting material selection, production process and the control of the final product is not strict enough phenomenon.
    In addition, because of the special route of injection, many products are used for special clinical purposes, such as drugs for acute and severe patients (e.g. anti-infective and anti-tumor drugs), medications for chronic patients (e.g. hypertension, diabetes, end-stage kidney disease), and medications for special populations (e.g. the elderly, infants, pregnant and lactating women).
    drugs themselves are also narrow therapeutic index products, which makes the safety control of injections very important.
    because the consistency evaluation has not yet entered the harvest period, the unested imitation injection can expand the market by entering the centralized drug procurement catalogue in the provinces and cities.
    the above-mentioned scholars believe that injections in the national collection catalog of less varieties, in the provincial and municipal band procurement more, but high-risk injections should carefully consider the belt procurement strategy.
    But many injections are clinically common drugs, involving a high amount of money, the use of large medical insurance funds, but also "quantity for price" demand;
    Unseeded products are monitored It is worth noting that, compared with other provinces with volume procurement programs, the five provincial alliances will monitor non-selected and not included in the volume of procurement products, and set up a list of violations, to give certain penalties and disciplinary measures.
    products not selected and products not included in the procurement of the same generic name and the same way of administration are all included in the monitoring and management, the amount of procurement in principle shall not be higher than the historical procurement volume of the previous year, and shall not exceed the quantity of the procurement of the selected drugs.
    Declare enterprises, selected enterprises, distribution enterprises, if the following acts, determined by the relevant departments serious circumstances will be included in the "violation list": including the provision of kickbacks or other commercial bribery, illegal promotional activities; If the declaring enterprise is included in the "violation list", the declaration qualification of the enterprise is cancelled;
    At the same time, depending on the seriousness of the circumstances, the above-mentioned enterprises shall be disqualified from participating in the centralized procurement activities of pharmaceutical supplies in the joint procurement areas within 2 years from the date of inclusion in the "violation list" and shall inform the State Health Insurance Administration and the departments of medical insurance, health care, market supervision and drug supervision of the provinces (cities).
    If the centralized monitoring of the purchase volume of unseeded products, means that the enterprise's back road completely blocked - can not be by giving up the winning bid, focus on expanding the hospital market, active promotion to obtain sales, because the purchase volume of the unseeded varieties must not be higher than the number of winning drug purchases.
    enterprises only actively reduce prices, and strive to win the bid to preserve the market.
    For enterprises, once the winning bid, not only to obtain the procurement market in five provinces, but also through the rules to limit the sales of competitive products, to achieve a new round of market volume, will certainly significantly reduce prices to obtain the winning bid qualification.
    means that a new price war is about to begin soon.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.